beta-lactamase
A beta-lactamase is a bacterial enzyme that chops open the beta-lactam ring at the heart of penicillins and cephalosporins, destroying the antibiotic before it can act. It is the bacteria's counterweapon — a pair of molecular scissors that snips the drug's warhead and renders it harmless.
Mechanistically, beta-lactamase recognizes the beta-lactam much as the drug's intended target does, but instead of being permanently jammed, the enzyme hydrolyzes the ring open and lets go, ready to destroy the next molecule. Bacteria can pump out enough of these enzymes to inactivate a drug faster than it can kill, which makes beta-lactamase one of the most important resistance mechanisms in medicine.
There are thousands of variants, evolving rapidly under antibiotic pressure: from simple penicillinases to extended-spectrum beta-lactamases that destroy many cephalosporins, up to carbapenemases that defeat even our last-resort beta-lactams. Chemists fight back with beta-lactamase inhibitors that sacrifice themselves to occupy the enzyme — but this remains an ongoing arms race rather than a settled victory.
Carbapenem-resistant Enterobacteriaceae produce carbapenemases that destroy carbapenems, leaving clinicians with very few remaining treatment options.
An enzyme that defeats last-resort antibiotics is a clinical emergency.
Beta-lactamase inhibitors like clavulanic acid, sulbactam, and tazobactam often have little antibacterial power of their own; their job is to protect the partner antibiotic.